학술논문
FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug Fumagillin (TNP-470).
Document Type
Article
Author
Source
Journal of Cellular Biochemistry; Aug2007, Vol. 101 Issue 6, p1492-1504, 13p
Subject
Language
ISSN
07302312